Jnj marketwatch.

Johnson & Johnson company facts, information and financial ratios from MarketWatch.The latest price target for . Johnson & Johnson (NYSE: JNJ) was reported by Cantor Fitzgerald on November 20, 2023.The analyst firm set a price target for $215.00 expecting JNJ to rise to within ...5 Okt 2023 ... Shares of Johnson & Johnson JNJ advanced 1.04% to $157.14 Thursday, on ... Subscribe to MarketWatch. Get this article and all of MarketWatch ...Johnson & Johnson company facts, information and financial ratios from MarketWatch.Got $2,500? 2 Top Stocks That You Can Buy and Hold for a Lifetime. (Motley Fool) Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments: Consumer Health, Pharmaceutical, and MedTech.

Johnson & Johnson SEC filings breakout by MarketWatch. View the JNJ U.S. Securities and Exchange Commission reporting information.

Johnson & Johnson company facts, information and financial ratios from MarketWatch.NEW BRUNSWICK, N.J., November 30, 2023--Johnson & Johnson MedTech1 today announced the completion of the acquisition2 of Laminar, Inc., a privately-held medical device company focused on eliminating the left atrial appendage (LAA) in patients with non-valvular atrial fibrillation (AFib). Johnson & Johnson MedTech acquired Laminar for an upfront ...

Complete Johnson & Johnson stock information by Barron's. View real-time JNJ stock price and news, along with industry-best analysis. NEW BRUNSWICK, N.J., November 30, 2023--Johnson & Johnson MedTech1 today announced the completion of the acquisition2 of Laminar, Inc., a privately-held medical device company focused on eliminating the left atrial appendage (LAA) in patients with non-valvular atrial fibrillation (AFib). Johnson & Johnson MedTech acquired Laminar for an upfront ...Johnson & Johnson company facts, information and financial ratios from MarketWatch.Stock analysis for Johnson & Johnson (JNJ:New York) including stock price, stock chart, company news, key statistics, fundamentals and company profile.JNJ | Complete Johnson & Johnson stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.

Johnson & Johnson company facts, information and financial ratios from MarketWatch.

Complete Johnson & Johnson stock information by Barron's. View real-time JNJ stock price and news, along with industry-best analysis.

Find the latest Johnson & Johnson (JNJ) stock quote, history, news and other vital information to help you with your stock trading and investing.Johnson & Johnson company facts, information and financial ratios from MarketWatch.Johnson & Johnson company facts, information and financial ratios from MarketWatch.Johnson & Johnson company facts, information and financial ratios from MarketWatch.Dec 1, 2023 · View Johnson & Johnson JNJ investment & stock information. Get the latest Johnson & Johnson JNJ detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. Johnson & Johnson company facts, information and financial ratios from MarketWatch.

Johnson & Johnson company facts, information and financial ratios from MarketWatch.Find real-time JNJ - Johnson & Johnson stock quotes, company profile, news and forecasts from CNN Business. Johnson & Johnson JNJ, -1.95% updated on Wednesday its 2023 financial guidance in the wake of the Kenvue Inc. KVUE, +0.31% separation that was completed last week.The drug maker now expects full ...Johnson & Johnson company facts, information and financial ratios from MarketWatch.Johnson & Johnson company facts, information and financial ratios from MarketWatch.

Oct 30, 2023 · Johnson & Johnson closed $34.01 below its 52-week high ($181.04), which the company achieved on December 14th. The stock underperformed when compared to some of its competitors Monday, as Procter ... Johnson & Johnson company facts, information and financial ratios from MarketWatch.

Find the latest Johnson & Johnson (JNJ) stock quote, history, news and other vital information to help you with your stock trading and investing.Johnson & Johnson company facts, information and financial ratios from MarketWatch.Q1 2024 EPS Estimate Trends. Johnson & Johnson analyst estimates, including JNJ earnings per share estimates and analyst recommendations.XE:JNJ - Johnson & Johnson Basic Chart, Quote and financial news from ... 06:25 AM ET. Johnson & Johnson stock climbs 1.7% premarket after Q3 results MarketWatch.Johnson & Johnson Annual stock financials by MarketWatch. View the latest JNJ financial statements, income statements and financial ratios.Johnson & Johnson company facts, information and financial ratios from MarketWatch. The latest price target for . Johnson & Johnson (NYSE: JNJ) was reported by Cantor Fitzgerald on November 20, 2023.The analyst firm set a price target for $215.00 expecting JNJ to rise to within ...

Analyst Forecast. According to 15 analysts, the average rating for JNJ stock is "Buy." The 12-month stock price forecast is $168.0, which is an increase of 10.45% from the latest price.

Johnson & Johnson Annual stock financials by MarketWatch. View the latest JNJ financial statements, income statements and financial ratios.

Johnson & Johnson beats earnings estimates and downplays obesity drugs’ impact on its med-tech business MarketWatch. 06:39 AM ET. J&J’s stock rallies after …26 Sep 2023 ... Shares of Johnson & Johnson JNJ slipped 0.77% to $159.02 Tuesday, on ... Subscribe to MarketWatch. Get this article and all of MarketWatch ...Johnson & Johnson SEC filings breakout by MarketWatch. View the JNJ U.S. Securities and Exchange Commission reporting information.Johnson & Johnson company facts, information and financial ratios from MarketWatch.Johnson & Johnson has a significant three-year median payout ratio of 61%, meaning that it is left with only 39% to reinvest into its business. This implies that the company has been able to ...6.25%. $80.46M. JNJ | Complete Johnson & Johnson stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.13 Jul 2018 ... According to MarketWatch, Johnson & Johnson "has been fighting more than 9,000 talcum-powder lawsuits with mixed success. It says its ...Johnson & Johnson SEC filings breakout by MarketWatch. View the JNJ U.S. Securities and Exchange Commission reporting information.The 71 analysts offering price forecasts for Johnson & Johnson have a median target of 184.06, with a high estimate of 215.00 and a low estimate of 40.00. The median estimate represents a 86.05 ...Johnson & Johnson company facts, information and financial ratios from MarketWatch.View Johnson & Johnson JNJ investment & stock information. Get the latest Johnson & Johnson JNJ detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.0.06%. £157.78B. Medtronic PLC. 0.77%. $105.07B. JNJ | Complete Johnson & Johnson stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.

Johnson & Johnson beats earnings estimates and downplays obesity drugs’ impact on its med-tech business MarketWatch. 06:39 AM ET. J&J’s stock rallies after …Johnson & Johnson options data by MarketWatch. View JNJ option chain data and pricing information for given maturity periods.JNJ | Complete Johnson & Johnson stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. 3 hari yang lalu ... Shares of Johnson & Johnson JNJ rallied 2.41% to $158.38 Friday, on ... Subscribe to MarketWatch. Get this article and all of MarketWatch ...Instagram:https://instagram. best mortgage floridahow much is a 1943 s steel penny worthelon musk manufactured homestrctf 4 days ago - Market Watch. Johnson & Johnson MedTech Acquires Laminar, Inc. NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--Johnson & Johnson MedTech1 today announced ...Q1 2024 EPS Estimate Trends. Johnson & Johnson analyst estimates, including JNJ earnings per share estimates and analyst recommendations. florida va loantop 10 real estate investment companies Johnson & Johnson company facts, information and financial ratios from MarketWatch.Johnson & Johnson company facts, information and financial ratios from MarketWatch. why is mytheresa cheaper 1 M 3 M YTD 1 Y 3 Y $ % Advanced Charting Compare Compare to Benchmark: DJIA S&P 500 GLOBAL DOW NASDAQ Health Care/Life Sciences Compare to Open 156.44 Prior …Johnson & Johnson company facts, information and financial ratios from MarketWatch.Johnson & Johnson company facts, information and financial ratios from MarketWatch.